FDA Inspection 1096160 — Sung Hye Yi, PhD
The FDA completed an inspection of Sung Hye Yi, PhD on June 26, 2019 in Anaheim, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 26, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Anaheim, CA (United States)
Additional Details
Clinical Investigator (CI)